Capsaicin Lipid Matrix pH-Dependent Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current capsaicin products for obesity management are ineffective due to low dosage and high production costs, as they release capsaicin in the stomach, causing discomfort and requiring expensive delayed release mechanisms.
Innovation Solution
A dietary composition with a lipid matrix that delays the release of capsaicinoids until the small intestine, allowing for higher concentrations of capsaicin to be absorbed, formulated as multiparticulates with a pH-dependent release mechanism, incorporating capsaicin wax and liquid extracts for controlled release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If capsaicin is released in the stomach using conventional delayed release mechanisms, then appetite suppression effectiveness is improved, but production cost increases significantly
Solution Approach 1:
The patent changes the pH sensitivity parameter of the release mechanism from conventional enteric coating (pH 5.5-6.0) to a novel pH-dependent lipid matrix system that releases capsaicin at pH 2.0-4.0 in the stomach, eliminating the need for expensive enteric coating processes while achieving effective delayed release
Solution Approach 2:
The patent uses a composite lipid matrix system combining pH-dependent lipids with capsaicin, creating a simple yet effective delivery mechanism that replaces complex conventional delayed release mechanisms and reduces production costs
2Object-affected harmful factors
If conventional enteric coated beadlets are used to delay capsaicin release, then gastrointestinal discomfort is reduced, but the dosage of capsaicin must be kept low which reduces effectiveness
Solution Approach 1:
The patent changes the release pH parameter to match the stomach environment (pH 2.0-4.0), allowing capsaicin to be released exactly where needed for maximum effectiveness while still avoiding direct contact with the stomach lining that causes discomfort
Solution Approach 2:
The pH-dependent lipid matrix acts as an intermediary carrier that protects capsaicin from direct contact with gastric tissues while delivering it to the small intestine, enabling both high dosage and reduced gastrointestinal side effects
3Reliability
If capsaicin is released in the small intestine, then bioavailability and efficacy are enhanced, but conventional delayed release mechanisms are required which increase production cost
Solution Approach 1:
The patent modifies the pH-dependent release parameter to occur at pH 6.5 or greater in the small intestine, achieving enhanced bioavailability while using a simple lipid matrix system that is much cheaper to produce than conventional enteric coated beadlets
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances bioavailability and efficacy of capsaicinoids for appetite suppression and metabolic control, reducing gastrointestinal discomfort and production costs, enabling effective weight management with higher capsaicin doses.
Implementation Method 1
The dietary composition can be particularly formulated so as to release the one or more capsaicinoids when the composition is in an environment at pH of about 6.5 or greater
Implementation Method 2
The lipid multiparticulates are acid resistant
Implementation Method 3
the capsaicin is absorbed into the body through the small intestine
Data Source
AI summary
A composition, such as a dietary composition is disclosed containing one or more capsaicinoids contained within a lipid matrix. In one embodiment, the composition contains a liquid capsaicin in addition to a capsaicin wax. The composition is formulated such that when is ingested does not break down in the stomach but instead releases the capsaicin in the small intestines for various dietary benefits, including appetite suppression.